Renal Transplant Rejection
📧 Sign up to get email alerts when something new happens for Renal Transplant Rejection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Simulect Versus ATG in Sensitized Renal Transplant Patient [Phase 4]
Phase 4 trial comparing basiliximab (Simulect) versus antithymocyte globulin (ATG) in sensitized renal transplant patients has completed.
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Heme Arginate in Transplantation Study [Phase 3]
A Phase 3 study of Heme Arginate in renal transplantation (rejection and failure) has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: Switch to Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/F/TAF) After Renal Transplant [Phase 4]
Phase 4 trial evaluating switching HIV-infected kidney transplant recipients to Bictegravir/emtricitabine/tenofovir alafenamide (Biktarvy). …
-
CLINICAL_TRIALS trial_result · 2024-09-03Clinical Trial Update: AlloSure for the Monitoring of Antibody Mediated Processes After Kidney Transplantation
A completed clinical trial evaluating AlloSure for monitoring antibody-mediated processes after kidney transplantation.
-
CLINICAL_TRIALS trial_result · 2024-07-17Clinical Trial Update: Envarsus on the Effect of Total Tacrolimus Dose/Trough Level Ratio on Renal Function (eGFR) in Kidney Transplantation [Phase 4]
Phase 4 study evaluating whether the ratio of total tacrolimus dose to trough level with Envarsus affects renal function (eGFR) in kidney tr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-09-05Clinical Trial Update: Induction in Sensitized Kidney Transplant Recipients Without Pre-existing Donor-specific antiboDies [Phase 3]
Phase 3 clinical trial evaluating induction therapy in sensitized kidney transplant recipients without pre-existing donor-specific antibodie…
-
CLINICAL_TRIALS trial_result · 2023-04-10Clinical Trial Update: Extended Release Tacrolimus vs. Twice-Daily Tacrolimus [Phase 3]
Phase 3 trial comparing extended-release tacrolimus to twice-daily tacrolimus in renal transplant patients; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2023-03-06Clinical Trial Update: Contrast Enhanced Ultrasonography to Detect Human Renal Transplant Rejection [Phase 2]
Phase 2 clinical trial evaluating contrast-enhanced ultrasonography for detecting renal transplant rejection has been completed.
-
CLINICAL_TRIALS trial_result · 2022-12-13Clinical Trial Update: Mechanisms of Belatacept Effect on Alloimmunity and Antiviral Response After Kidney Transplantation (BMS IM 103-309) [Phase 4]
Phase 4 trial update exploring how belatacept modulates alloimmune and antiviral responses after kidney transplantation, with completed stat…
-
CLINICAL_TRIALS trial_result · 2022-01-18Clinical Trial Update: Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection (AMR) in Adult Renal Transplant Recipients [Phase 3]
A Phase 3 trial evaluating human plasma-derived C1-esterase inhibitor as add-on therapy to standard of care for refractory antibody-mediated…
-
CLINICAL_TRIALS trial_result · 2021-01-29Clinical Trial Update: Tacrolimus After rATG and Infliximab Induction Immunosuppression (RIMINI) [Phase 2]
Phase 2 trial update examining tacrolimus after rATG and infliximab induction immunosuppression for renal transplant rejection has completed…
-
CLINICAL_TRIALS trial_result · 2020-09-17Clinical Trial Update: Mesenchymal Stromal Cell Therapy in Renal Recipients [Phase 2]
Phase 2 trial update of mesenchymal stromal cell therapy for renal transplant rejection and fibrosis in renal recipients.
-
CLINICAL_TRIALS trial_result · 2020-04-14Clinical Trial Update: Steroid Withdrawal and Donor-specific Anti-HLA Antibodies in Renal Transplant Patients [Phase 4]
Phase 4 trial update on steroid withdrawal and donor-specific anti-HLA antibodies in renal transplant patients; completed with results poste…
-
CLINICAL_TRIALS trial_result · 2019-10-21Clinical Trial Update: Cytokines Evaluation in Early Calcineurin Inhibitors Withdrawn on Renal Transplant [Phase 4]
Phase 4 clinical trial evaluating cytokines in early withdrawal of calcineurin inhibitors for renal transplant patients has completed with r…
-
CLINICAL_TRIALS trial_result · 2019-05-31Clinical Trial Update: Randomized Conversion of Calcineurin-Inhibitors in Renal Allograft Recipients [Phase 4]
Phase 4 randomized trial evaluating conversion strategies for calcineurin inhibitors in renal transplant recipients; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-04-22Clinical Trial Update: Belimumab Impacting Transplant Eligibility [Phase 1, Phase 2]
Phase 1/2 trial evaluating belimumab and its impact on transplant eligibility in renal transplant rejection patients; study completed.
-
CLINICAL_TRIALS trial_result · 2018-08-22Clinical Trial Update: Efficacy of Rituximab in Acute Cellular Rejection in Renal Transplant Patients [Phase 3]
Phase 3 clinical trial evaluating rituximab for acute cellular rejection in renal transplant patients was terminated.
-
CLINICAL_TRIALS trial_result · 2018-03-06Clinical Trial Update: Testing Immunosuppression Threshold in Renal Allografts To Extend eGFR [NA]
A completed clinical trial evaluating whether adjusting immunosuppression thresholds in renal transplant recipients can extend estimated glo…
-
CLINICAL_TRIALS trial_result · 2017-08-10Clinical Trial Update: Diagnosis of Acute Rejection in Renal Transplant Patients by Urine Mass Spectrometry
This update reports on a clinical trial evaluating urine mass spectrometry as a diagnostic test for acute rejection in kidney transplant pat…
-
CLINICAL_TRIALS trial_result · 2017-06-27Clinical Trial Update: Imaging Kidney Transplant Rejection Using Ferumoxytol-Enhanced Magnetic Resonance [NA]
A Stanford-sponsored clinical trial evaluating ferumoxytol-enhanced MRI for imaging renal transplant rejection has completed and posted resu…
-
CLINICAL_TRIALS trial_result · 2016-11-08Clinical Trial Update: To Elucidate the Effect of Mesenchymal Stem Cells on the T Cell Repertoire of the Kidney Transplant Patients [Phase 1]
A Phase 1 clinical trial evaluating the impact of mesenchymal stem cells on the T cell repertoire in renal transplant recipients.
-
CLINICAL_TRIALS trial_result · 2015-11-23Clinical Trial Update: Prospective Pilot Study of Pre-Transplant Thymoglobulin Administration in Living Donor Renal Transplant Recipients [Phase 4]
A Phase 4 pilot study evaluating pre-transplant thymoglobulin to prevent rejection in living-donor kidney transplant recipients has complete…
-
CLINICAL_TRIALS trial_result · 2015-10-20Clinical Trial Update: A Trial Comparing Prograf and Neoral Use in Kidney Transplant Recipients of Hispanic Ethnicity [Phase 4]
Phase 4 trial comparing tacrolimus (Prograf) and cyclosporine (Neoral) in kidney transplant recipients; the study was terminated and results…
-
CLINICAL_TRIALS trial_result · 2015-05-01Clinical Trial Update: Efficacy and Safety of ATG-Fresenius Following a Renal Transplantation, Without Corticosteroids [Phase 3]
Phase 3 trial of ATG-Fresenius after renal transplantation without corticosteroids was terminated. The update reports on the efficacy and sa…
-
CLINICAL_TRIALS trial_result · 2015-03-18Clinical Trial Update: A Study to Evaluate the Effect of Thymoglobulin and Reduced Doses of Steroids to Prevent Renal Transplant Rejection [Phase 2]
Phase 2 study evaluating thymoglobulin with reduced steroid doses to prevent rejection in kidney transplant recipients; study completed.